{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-282873","form_type":"8-K","ticker":"FULC","cik":"0001680581","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2026-06-25T20:32:25+00:00","discovered_at":"2026-06-25T20:33:00.364233+00:00","generated_at":"2026-06-25T20:33:12.392571+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Fulcrum stockholders elect three Class I directors, approve advisory compensation, ratify auditor","bullets":["Sonja Banks, Alan Ezekowitz, Colin Hill elected as Class I directors for three-year terms ending 2029.","Advisory vote on named executive officer compensation approved with 50.7M for, 3.0M against.","Ratification of Ernst & Young as FY2026 auditor approved with 58.8M for, 36K against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-282873","json":"https://secwatch.observer/filing/0001193125-26-282873.json","markdown":"https://secwatch.observer/filing/0001193125-26-282873.md","text":"https://secwatch.observer/filing/0001193125-26-282873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526282873/0001193125-26-282873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526282873/d159102d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T20:33:12.392571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}